The UK is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the familiar use of psilocybin and LSD, scientists and explorers are increasingly focused on less-charted territories, particularly copyright and the budding cannabinoid, cannabigerol. This expanding community encompasses therapeutic research into emotion